JP2013532629A - ナノ粒子誘導放射線治療 - Google Patents

ナノ粒子誘導放射線治療 Download PDF

Info

Publication number
JP2013532629A
JP2013532629A JP2013519107A JP2013519107A JP2013532629A JP 2013532629 A JP2013532629 A JP 2013532629A JP 2013519107 A JP2013519107 A JP 2013519107A JP 2013519107 A JP2013519107 A JP 2013519107A JP 2013532629 A JP2013532629 A JP 2013532629A
Authority
JP
Japan
Prior art keywords
imaging
nano
sized particles
particles
target tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013519107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013532629A5 (https=
Inventor
ラース アンドレセン トマス
アルブレシュトセン モルテン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danmarks Tekniske Universitet
Original Assignee
Danmarks Tekniske Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danmarks Tekniske Universitet filed Critical Danmarks Tekniske Universitet
Publication of JP2013532629A publication Critical patent/JP2013532629A/ja
Publication of JP2013532629A5 publication Critical patent/JP2013532629A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48Diagnostic techniques
    • A61B6/481Diagnostic techniques involving the use of contrast agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/0035Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03Computed tomography [CT]
    • A61B6/032Transmission computed tomography [CT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03Computed tomography [CT]
    • A61B6/037Emission tomography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/481Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414Particles, beads, capsules or spheres
    • A61K49/0423Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414Particles, beads, capsules or spheres
    • A61K49/0423Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/0428Surface-modified nanoparticles, e.g. immuno-nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103Treatment planning systems
    • A61N5/1039Treatment planning systems using functional images, e.g. PET or MRI
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1049Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1064Monitoring, verifying, controlling systems and methods for adjusting radiation treatment in response to monitoring
    • A61N5/1065Beam adjustment
    • A61N5/1067Beam adjustment in real time, i.e. during treatment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4064Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam
    • A61B6/4092Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam for producing synchrotron radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1049Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
    • A61N2005/1061Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using an x-ray imaging system having a separate imaging source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Optics & Photonics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Pulmonology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
JP2013519107A 2010-07-16 2011-07-15 ナノ粒子誘導放射線治療 Pending JP2013532629A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36491710P 2010-07-16 2010-07-16
EP10169862.9 2010-07-16
EP10169862 2010-07-16
US61/364,917 2010-07-16
PCT/EP2011/062122 WO2012007567A1 (en) 2010-07-16 2011-07-15 Nanoparticle-guided radiotherapy

Publications (2)

Publication Number Publication Date
JP2013532629A true JP2013532629A (ja) 2013-08-19
JP2013532629A5 JP2013532629A5 (https=) 2015-12-10

Family

ID=43063934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013519107A Pending JP2013532629A (ja) 2010-07-16 2011-07-15 ナノ粒子誘導放射線治療

Country Status (9)

Country Link
US (1) US20130204121A1 (https=)
EP (1) EP2593186A1 (https=)
JP (1) JP2013532629A (https=)
CN (1) CN103079642A (https=)
AU (1) AU2011278308B2 (https=)
BR (1) BR112013000907A2 (https=)
CA (1) CA2804849A1 (https=)
MX (1) MX2013000501A (https=)
WO (1) WO2012007567A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088731A1 (ja) * 2014-12-02 2016-06-09 シグマテクノロジー有限会社 マイクロ・ナノバブルによる洗浄方法及び洗浄装置
WO2016137013A1 (ja) * 2015-02-26 2016-09-01 国立大学法人北海道大学 放射線治療用の病変識別マーカーおよび放射線治療用の病変識別マーカーキット
WO2018038223A1 (ja) * 2016-08-25 2018-03-01 国立大学法人北海道大学 骨セメントを活用した放射線治療用の病変識別マーカーおよび放射線治療用の病変識別マーカーキット

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2782603A1 (en) 2011-11-25 2014-10-01 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system
US9370490B2 (en) 2012-02-28 2016-06-21 Loma Linda University Methods for the production, modification and use of metallic nanoparticles
WO2013164725A1 (en) 2012-05-02 2013-11-07 Koninklijke Philips N.V. Spectral ct visualization of imageable drug eluting beads
US10035009B2 (en) 2013-04-15 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treating pancreatic cancer
RU2703303C2 (ru) * 2013-05-24 2019-10-16 Данмаркс Текниске Университет Состав геля для лучевой терапии под визуальным контролем
FR3018451A1 (fr) * 2014-03-13 2015-09-18 Chromalys Nanoparticules pour leur utilisation dans la detection de tumeurs mobiles
CN103894557B (zh) * 2014-03-19 2016-01-20 丽水市中心医院 磁共振成像下可视的功能化金纳米粒子的制备方法及应用
US10004695B2 (en) 2014-04-16 2018-06-26 Trustees Of Boston University GM3 functionalized nanoparticles
WO2016004222A1 (en) * 2014-07-01 2016-01-07 Georgia Regents University Bio-compatible radiopaque dental fillers for imaging
WO2016115140A1 (en) * 2015-01-13 2016-07-21 Boston Scientific Scimed, Inc. Cancer cell membrane depolarization
CA3015663A1 (en) * 2016-03-07 2017-09-14 Memorial Sloan Kettering Cancer Center Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use
KR102162400B1 (ko) * 2016-05-13 2020-10-06 시그마 테크놀로지 유겐가이샤 생체 투여 가능한 수용액 및 그 제조 방법
EP3500311B1 (en) 2016-08-16 2020-05-27 ETH Zurich Transmembrane ph-gradient polymersomes and their use in the scavenging of ammonia and its methylated analogs
WO2019028453A1 (en) * 2017-08-04 2019-02-07 The Cleveland Clinic Foundation RADIATION THERAPY WITH TEMPORAL ATTENUATION
DK3668927T3 (da) 2017-09-12 2024-03-25 Eth Zuerich Transmembran ph-gradient polymersom til kvantificering af ammoniak i kropsvæsker
IL265914B (en) * 2019-04-08 2020-11-30 Convergent R N R Ltd System and method for optimization of radiotherapy treatments
FR3099052B1 (fr) * 2019-07-23 2022-03-25 Univ Franche Comte Structures particulaires à base de nanoparticules d’or, leurs procédés de préparation et leurs utilisations dans le traitement des tumeurs solides
US10929981B1 (en) * 2019-08-21 2021-02-23 Ping An Technology (Shenzhen) Co., Ltd. Gross tumor volume segmentation method and computer device
US12082956B2 (en) * 2019-09-09 2024-09-10 Universidad De La Frontera Integral systems of orthovoltage sources that induce ionizing radiation
CN111467174B (zh) * 2019-12-20 2023-02-17 联影(常州)医疗科技有限公司 一种头部固定装置、血管减影造影系统及透射方法
IT202000001048A1 (it) 2020-01-21 2021-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.
IT202100001049A1 (it) 2021-01-21 2022-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075961A2 (en) * 2002-03-08 2003-09-18 James Hainfeld Gold nanoparticles used for x-rays imaging
JP2006507864A (ja) * 2002-11-28 2006-03-09 エレクタ、アクチボラグ 放射線治療装置およびその操作方法
JP2006297095A (ja) * 2005-04-20 2006-11-02 Siemens Ag 患者のコンピュータ断層撮影画像データセットの作成および照射システム
JP2009508924A (ja) * 2005-09-22 2009-03-05 アイオン・ダイアグノステイツクス・リミテツド シリコンを含む造影剤
WO2009049083A1 (en) * 2007-10-09 2009-04-16 Washington University In St. Louis Particles for imaging

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US6645464B1 (en) * 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
JP4282302B2 (ja) * 2001-10-25 2009-06-17 株式会社東芝 X線ct装置
WO2004017814A2 (en) 2002-08-23 2004-03-04 The Board Of Regents Of University Of Texas System Novel method and composition of identifying inflammation by cat scan
JP4247533B2 (ja) * 2003-09-03 2009-04-02 国立大学法人東京工業大学 呼吸同期装置
WO2005046733A1 (en) * 2003-11-17 2005-05-26 Philips Intellectual Property & Standards Gmbh Contrast agent for medical imaging techniques and usage thereof
US20070031337A1 (en) * 2004-06-22 2007-02-08 Reinhard Schulte Nanoparticle enhanced proton computed tomography and proton therapy
WO2006084382A1 (en) 2005-02-11 2006-08-17 University Health Network Compositions and methods for multimodal imaging
WO2007129311A2 (en) 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
KR100810679B1 (ko) * 2006-05-09 2008-03-07 원광대학교산학협력단 금 나노입자를 이용한 엑스-선 조영제 및 이의 제조방법
US7906147B2 (en) * 2006-10-12 2011-03-15 Nanoprobes, Inc. Functional associative coatings for nanoparticles
US20080213189A1 (en) * 2006-10-17 2008-09-04 The Board Of Trustees Of The Leland Stanford Junior University Multifunctional metal-graphite nanocrystals
WO2008096279A1 (en) * 2007-02-07 2008-08-14 Spago Imaging Ab Compositions containing metal oxide particles and their uses
US20090088625A1 (en) * 2007-10-01 2009-04-02 Kenneth Oosting Photonic Based Non-Invasive Surgery System That Includes Automated Cell Control and Eradication Via Pre-Calculated Feed-Forward Control Plus Image Feedback Control For Targeted Energy Delivery
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres
WO2009155431A1 (en) * 2008-06-18 2009-12-23 University Of Louisville Research Foundation, Inc. Methods for targeted cancer treatment and detection
US8784800B2 (en) * 2009-03-09 2014-07-22 Medtronic, Inc. Method of delivering cell therapy to a target site
DK3223013T3 (en) * 2009-07-02 2019-04-15 Sloan Kettering Inst Cancer Res FLUORESCING SILICA-BASED NANOPARTICLES

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075961A2 (en) * 2002-03-08 2003-09-18 James Hainfeld Gold nanoparticles used for x-rays imaging
JP2006507864A (ja) * 2002-11-28 2006-03-09 エレクタ、アクチボラグ 放射線治療装置およびその操作方法
JP2006297095A (ja) * 2005-04-20 2006-11-02 Siemens Ag 患者のコンピュータ断層撮影画像データセットの作成および照射システム
JP2009508924A (ja) * 2005-09-22 2009-03-05 アイオン・ダイアグノステイツクス・リミテツド シリコンを含む造影剤
WO2009049083A1 (en) * 2007-10-09 2009-04-16 Washington University In St. Louis Particles for imaging

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088731A1 (ja) * 2014-12-02 2016-06-09 シグマテクノロジー有限会社 マイクロ・ナノバブルによる洗浄方法及び洗浄装置
JPWO2016088731A1 (ja) * 2014-12-02 2017-10-05 シグマテクノロジー有限会社 マイクロ・ナノバブルによる洗浄方法及び洗浄装置
US10632506B2 (en) 2014-12-02 2020-04-28 Sigma-Technology Inc. Cleaning method and cleaning device using micro/nano-bubbles
WO2016137013A1 (ja) * 2015-02-26 2016-09-01 国立大学法人北海道大学 放射線治療用の病変識別マーカーおよび放射線治療用の病変識別マーカーキット
WO2018038223A1 (ja) * 2016-08-25 2018-03-01 国立大学法人北海道大学 骨セメントを活用した放射線治療用の病変識別マーカーおよび放射線治療用の病変識別マーカーキット

Also Published As

Publication number Publication date
AU2011278308A1 (en) 2013-01-31
BR112013000907A2 (pt) 2017-10-31
CN103079642A (zh) 2013-05-01
AU2011278308B2 (en) 2014-09-04
EP2593186A1 (en) 2013-05-22
US20130204121A1 (en) 2013-08-08
WO2012007567A1 (en) 2012-01-19
CA2804849A1 (en) 2012-01-19
MX2013000501A (es) 2013-06-05

Similar Documents

Publication Publication Date Title
AU2011278308B2 (en) Nanoparticle-guided radiotherapy
US11529316B2 (en) Ultrafine nanoparticles as multimodal contrast agent
Guo et al. pH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranostics
KR102385193B1 (ko) 암 치료용 이온화 방사선과 조합된 무기 나노입자 조성물
Pellico et al. Radiolabeled iron oxide nanomaterials for multimodal nuclear imaging and positive contrast magnetic resonance imaging (MRI): a review
Bonlawar et al. Targeted nanotheranostics: integration of preclinical MRI and CT in the molecular imaging and therapy of advanced diseases
Gupta et al. Metallic nanoparticles for CT-guided imaging of tumors and their therapeutic applications
US20090317327A1 (en) Aqueous Dispersion of Superparamagnetic Single-Domain Particles, Production and Use Thereof in Diagnosis and Therapy
US20230330229A1 (en) Methods for image-guided radiotherapy
US20150064107A1 (en) Imaging agent
CN110382010A (zh) 铋-钆纳米颗粒
CN116472067A (zh) 用于制备纳米颗粒的方法
KR102681399B1 (ko) 산화철 자성 입자를 포함하는 간암치료용 조성물의 제조방법
KR102698260B1 (ko) 산화철 자성 입자를 포함하는 간암치료용 조성물
Gupta et al. Nanoparticles in CT-Guided Interventional Devices and Processes
Fernández Barahona Nanomaterials for multimodal molecular imaging
Fragogeorgi et al. Nuclear/MR Magnetic Nanoparticle‐based Probes for Multimodal Biomedical Imaging
Nandasana et al. Engineered materials for improving various imaging modalities
Cui et al. Synthesis, characterization, and application of core-shell Co₀. ₁₆Fe₂. ₈₄O₄@ NaYF₄ (Yb, Er) and Fe₃O₄@ NaYF₄ (Yb, Tm) nanoparticle as trimodal (MRI, PET/SPECT, and optical) imaging agents
Wang Advanced Materials for the Delivery of Anti‐Cancer Compounds and Imaging Contrast Agents
Tran Synthesis, Functionalization and Characterization of Ultrasmall Hybrid Silica Nanoparticles for Theranostic Applications
Barrefelt Theranostics in Radiology: Development of targeted contrast media with treatment capability
Schaarup-Jensen Synthesis and Development of Diagnostic Tools for Medical Imaging
Barrefelt Intervention and Technology (CLINTEC), Division of Medical Imaging and Technology Karolinska Institutet, Stockholm, Sweden
Christofi A dissertation research project

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140711

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150707

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151007

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20151022

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160301